These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6358361)

  • 1. An ELISA method for quantitation of macrophage migration from agarose microdroplets.
    Peck R
    J Immunol Methods; 1983 Nov; 64(1-2):179-87. PubMed ID: 6358361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of assay conditions for macrophage migration from an agarose droplet.
    Fahlbusch B; Dornberger G
    Acta Biol Med Ger; 1979; 38(10):1453-60. PubMed ID: 44954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
    Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
    Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors.
    Thurman GB; Stull HB; Miller PJ; Stevenson HC; Oldham RK
    J Immunol Methods; 1983 Dec; 65(1-2):41-53. PubMed ID: 6361142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibition factor (MIF): reducing the variables.
    MacSween JM; Rajaraman K; Rajaraman R; Fox RA
    J Immunol Methods; 1982; 52(1):127-36. PubMed ID: 6288804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A simplified macrophage migration inhibition test to measure T-cell derived immunity in man].
    Rehn K; Baake H; Hunstein W
    Klin Wochenschr; 1975 Apr; 53(8):397-9. PubMed ID: 802669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lotus tetragonolobus fucolectin as a potential model for "MIF-like" modulation of macrophage function: comparison of the interaction of Lotus fucose binding protein (FBP) and migration inhibitory factor (MIF) with macrophages in the migration inhibition assay.
    Leu RW; Whitley SB; Herriott J; Huddleston DJ
    Cell Immunol; 1980 Jul; 52(2):414-28. PubMed ID: 7002321
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes.
    Mizue Y; Nishihira J; Miyazaki T; Fujiwara S; Chida M; Nakamura K; Kikuchi K; Mukai M
    Int J Mol Med; 2000 Apr; 5(4):397-403. PubMed ID: 10719057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF).
    Higgins TJ; Sabatino AP; Remold HG; David JR
    J Immunol; 1978 Sep; 121(3):880-6. PubMed ID: 357658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of soluble lymphocyte mediators. VI. Effect of migration inhibitory factor (MIF) on macrophage microtubules.
    Pick E; Honig S; Griffel B
    Int Arch Allergy Appl Immunol; 1979; 58(2):149-59. PubMed ID: 370028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of macrophage activation on the response to migration inhibitory factor (MIF).
    Leu RW; Woodson PD; Whitley SB
    J Reticuloendothel Soc; 1977 Oct; 22(4):329-40. PubMed ID: 336882
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between agarose microdroplet and capillary tube procedures as assays for migration inhibition of target cells.
    Adelman N; Hasson M; Masih N; Cohen MC
    J Immunol Methods; 1980; 34(3):235-42. PubMed ID: 6995527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method using [3H]leucine-labeled granulocytes or macrophages for migration inhibition assay.
    Sandru G
    J Immunol Methods; 1984 Apr; 69(1):23-32. PubMed ID: 6371141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration inhibitory factors and macrophage differentiation.
    Sorg C; Michels E; Malorny U; Neumann C
    Springer Semin Immunopathol; 1984; 7(4):311-20. PubMed ID: 6395408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation.
    Makita H; Nishimura M; Miyamoto K; Nakano T; Tanino Y; Hirokawa J; Nishihira J; Kawakami Y
    Am J Respir Crit Care Med; 1998 Aug; 158(2):573-9. PubMed ID: 9700137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A; McCoy JL; Herberman RB
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advantages and technical conditions of the migration inhibition test [MIF] in agarose gel (author's transl)].
    Cabarcos A; Pérez-Miranda M; Uribarrena R; Pons F
    Sangre (Barc); 1977; 22(5):541-9. PubMed ID: 333629
    [No Abstract]   [Full Text] [Related]  

  • 18. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identity of specific macrophage-active human lymphokines.
    Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
    Lancet; 1978 Apr; 1(8066):718-9. PubMed ID: 76257
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis.
    Leech M; Metz C; Santos L; Peng T; Holdsworth SR; Bucala R; Morand EF
    Arthritis Rheum; 1998 May; 41(5):910-7. PubMed ID: 9588744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.